Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
Editorial Group: Cochrane Movement Disorders Group
Published Online: 18 OCT 2004
Assessed as up-to-date: 6 JUN 2004
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Deane K, Spieker S, Clarke CE. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease. Cochrane Database of Systematic Reviews 2004, Issue 4. Art. No.: CD004554. DOI: 10.1002/14651858.CD004554.pub2.
- Publication Status: Edited (no change to conclusions)
- Published Online: 18 OCT 2004
This article has been cited by:
- 1Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease, CNS Neuroscience & Therapeutics, 2008, 14, 1, 83,